Cargando…
Systematic review: fluid biomarkers and machine learning methods to improve the diagnosis from mild cognitive impairment to Alzheimer’s disease
Mild cognitive impairment (MCI) is often considered an early stage of dementia, with estimated rates of progression to dementia up to 80–90% after approximately 6 years from the initial diagnosis. Diagnosis of cognitive impairment in dementia is typically based on clinical evaluation, neuropsycholog...
Autores principales: | Blanco, Kevin, Salcidua, Stefanny, Orellana, Paulina, Sauma-Pérez, Tania, León, Tomás, Steinmetz, Lorena Cecilia López, Ibañez, Agustín, Duran-Aniotz, Claudia, de la Cruz, Rolando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576366/ https://www.ncbi.nlm.nih.gov/pubmed/37838690 http://dx.doi.org/10.1186/s13195-023-01304-8 |
Ejemplares similares
-
Systematic Review: microRNAs as Potential Biomarkers in Mild Cognitive Impairment Diagnosis
por: Ogonowski, Natalia, et al.
Publicado: (2022) -
Systematic Review: Genetic, Neuroimaging, and Fluids Biomarkers for Frontotemporal Dementia Across Latin America Countries
por: Duran-Aniotz, Claudia, et al.
Publicado: (2021) -
Associations of body mass index and sarcopenia with screen-detected mild cognitive impairment in older adults in Colombia
por: O’Donovan, Gary, et al.
Publicado: (2022) -
The burden of mild cognitive impairment attributable to physical inactivity in Colombia
por: O’Donovan, Gary, et al.
Publicado: (2022) -
P300 and Neuropsychological Assessment in Mild Cognitive Impairment and Alzheimer Dementia
por: Parra, Mario A., et al.
Publicado: (2012)